.png)
Mar 31, 2026
Supporting Confident Manufacturing Changes: How c-LEcta Helps You Navigate FDAs New Regulatory Flexibility
In January 2026, the U.S. FDA publicly reinforced aflexible, risk-based approach to CMC...
read more
Oct 7, 2025
c-LEcta introduces a new GMP Cell Dissociation Enzyme for Biopharmaceutical Manufacturing
c-LEcta, a Kerry company, announces the launch of CellTrypase, a new recombinant trypsin-like...
read more
